BioNTech And Pfizer To Seek Emergency Authorization For Covid-19 Vaccination Unlisted Video
3 years ago
347
BioNTech and its partner, Pfizer, will seek emergency approval for their Covid-19 vaccine candidate.
The drug companies will file paperwork for the emergency use of the vaccine with the US Food and Drug Administration (FDA).
In a final analysis of the Phase 3 trial, the vaccine was found to be 95% effective in preventing Covid-19.
The vaccine has been shown to work in all age populations.
According to CNN, the new vaccine has shown no serious safety concerns.
Drug company execs predict distribution to begin before the end of 2020.
Loading comments...
-
1:03
Newsy
3 years agoFDA Approves Emergency Authorization For COVID-19 Saliva Test
8031 -
2:00
WCPO
3 years agoPfizer: COVID-19 vaccine 90% effective
2.73K15 -
2:03
KGTV
3 years agoPfizer announces COVID-19 vaccine progress
3.52K -
2:43
KTNV
3 years agoPfizer announces more information about COVID-19 vaccine
21.2K4 -
2:08
KMGH
3 years agoPfizer says COVID-19 vaccine is looking 90% effective
6501 -
0:40
KERO
3 years agoFDA authorizes COVID-19 emergency pool testing
107 -
0:55
WFTS
3 years agoPfizer says its COVID-19 vaccine candidate is 90% effective
2.44K2 -
1:47
KSHB
3 years agoKC doctors speak out about Pfizer COVID-19 vaccine trail
7.12K21 -
0:20
KTNV
3 years agoPfizer to begin testing COVID-19 vaccine in 4 states
3.08K11 -
0:27
Newsy
3 years agoPfizer Allowed To Test COVID-19 Vaccine On Children
1.41K9
